A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Condition:   Asthma
Interventions:   Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler;   Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler;   Drug: NEUMOTEX 400 (Budesonide 400 mcg);   Drug: Salbutamol 100 mcg pMDI
Sponsors:   GlaxoSmithKline;   Laboratorios Phoenix
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.